PDCD1 and colorectal carcinoma: To identify the circRNAs that might be associated with CRC immune evasion and anti-PD-1 efficacy, we conducted circRNA microarray analysis using 32 CRC samples (13 responsive and 19 resistant to PD-1 antibody treatment).